Monica Biscaldi-Schäfer

Dr. Monica Biscaldi-Schäfer


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2013 in European Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
MBMonica Biscaldi-Schäfer
Monica Biscaldi-Schäfer
RRReinhold Rauh
Reinhold Rauh
LILisa Irion
Lisa Irion
NJNikolai H. Jung
Nikolai H. Jung
VMVolker Mall
Volker Mall
CKChristoph Klein
Christoph Klein

7 March 2017 in Molecular Autism
Verified
Journal Article
Open access
PDF file
DEDominique Endres
Dominique Endres
LELudger Tebartz van Elst
Ludger Tebartz van Elst
SMSimon A. Meyer
Simon A. Meyer
BFBernd Feige
Bernd Feige
KNKathrin Nickel
Kathrin Nickel
EPEvgeniy Perlov
Evgeniy Perlov
Autism spectrum disorder (ASD) is a neurodevelopmental disease characterized by difficulties in social communication, unusually restricted, repetitive behavior and interests, and specific abnormalities in language and perception. The precise etiology of ASD is still unknown and probably heterogeneous. In a subgroup of patients, toxic environmental exposure might lead to an imbalance between oxidative stress and anti-oxidant systems. Previous serum and postmortem studies measuring levels of glutathione (GSH), the main cellular free radical scavenger in the brain, have supported the hypothesis that this compound might play a role in the pathophysiology of autism. Using the method of single-voxel proton magnetic resonance spectroscopy (MRS), we analyzed the GSH signal in the dorsal anterior cingulate cortex (dACC) and the dorsolateral prefrontal cortex (DLPFC) of 24 ASD patients with normal or above average IQs and 18 matched control subjects. We hypothesized that we would find decreased GSH concentrations in both regions. We did not find overall group differences in neurometabolites including GSH, neither in the dorsal ACC (Wilks’ lambda test; p = 0.429) nor in the DLPFC (p = 0.288). In the dACC, we found a trend for decreased GSH signals in ASD patients (p = 0.076). We were unable to confirm our working hypothesis regarding decreased GSH concentrations in the ASD group. Further studies combining MRS, serum, and cerebrospinal fluid measurements of GSH metabolism including other regions of interest or even whole brain spectroscopy are needed.

2 August 2015 in European Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
MBMonica Biscaldi-Schäfer
Monica Biscaldi-Schäfer
RRReinhold Rauh
Reinhold Rauh
CMCora Müller
Cora Müller
LILisa Irion
Lisa Irion
CSChristopher W. N. Saville
Christopher W. N. Saville
CKChristoph Klein
Christoph Klein

18 July 2016 in Journal of Intelligence
Verified
Journal Article
Open access
PDF file
YSYoanna Schulz-Zhecheva
Yoanna Schulz-Zhecheva
MVManuel Voelkle
Manuel Voelkle
ABAndré Beauducel
André Beauducel
MBMonica Biscaldi-Schäfer
Monica Biscaldi-Schäfer
CKChristoph Klein
Christoph Klein
Mean reaction times (RT) and the intra-subject variability of RT in simple RT tasks have been shown to predict higher-order cognitive abilities measured with psychometric intelligence tests. To further explore this relationship and to examine its generalizability to a sub-adult-aged sample, we administered different choice RT tasks and Cattell’s Culture Fair Intelligence Test (CFT 20-R) to n = 362 participants aged eight to 18 years. The parameters derived from applying Ratcliff’s diffusion model and an ex-Gaussian model to age-residualized RT data were used to predict fluid intelligence using structural equation models. The drift rate parameter of the diffusion model, as well as σ of the ex-Gaussian model, showed substantial predictive validity regarding fluid intelligence. Our findings demonstrate that stability of performance, more than its mere speed, is relevant for fluid intelligence and we challenge the universality of the worst performance rule observed in adult samples.

30 April 2016 in Biological Psychology
Verified
Journal Article
Closed access
MBMonica Biscaldi-Schäfer
Monica Biscaldi-Schäfer
NBN. Bednorz
N. Bednorz
KWK. Weissbrodt
K. Weissbrodt
CSC.W.N. Saville
C.W.N. Saville
BFBernd Feige
Bernd Feige
CKC. Klein
C. Klein

1 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
GWGreta Walz
Greta Walz
NBNicola Blazynski
Nicola Blazynski
LFLukas Frey
Lukas Frey
KSKatja Schneider-Momm Katja Schneider-Momm
Katja Schneider-Momm Katja Schneider-Momm
HCHans-Willi Clement
Hans-Willi Clement
CFChristian Fleischhaker
Christian Fleischhaker
In the early 1920s, it was discovered that nutrition is associated with what is known today as Attention-Deficit/Hyperactivity Disorder (ADHD) and that certain foods can worsen the symptoms. In previous studies, approximately 60% of the participants experience at least a 40% reduction in ADHD symptoms after an oligoantigenic diet (OD). The purpose of this study was to evaluate ADHD symptoms in children approximately 3.5 years after completing a 4-week oligoantigenic diet. Among 28 participants who completed the 4-week diet, 21 were re-assessed for this study after 3.5 years. The severity of ADHD symptoms was assessed with the ADHD-Rating-Scale-IV (ARS). Of 21 participants, 14 fulfilled the responder criterion, whereas 7 did not. At follow-up, 28% of the participants were taking medication. The mean ARS total score improved significantly from T1: M = 29.62 (SD = 9.80) to T2: M = 15.86 (SD = 8.56) between the time points before and after the diet (d = −1.91). There was also a lower ARS total score at the follow-up T5: M = 16.00 (SD = 10.52) compared to before the diet (d = −1.17). This study shows that individually adjusted nutrition significantly improved the ADHD symptomatology of the participants long-term. This suggests that an oligoantigenic diet with subsequent individual nutritional recommendations could become an additional treatment option for children with ADHD.